Long-Term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients With Centrally Located Thoracic Tumors: SABR for Central Thoracic Tumors. (2020). Radiology and Oncology, 54(4), 480-487. https://radioloncol.com/index.php/ro/article/view/3439